An antitumor component from Fomitiporia ellipsoidea

Area of Science:

• Natural Product Chemistry
• Medicinal Chemistry
• Pharmacology

Background:

• Fomitiporia ellipsoidea is a fungal species known to produce bioactive compounds.
• Natural products are a rich source of potential therapeutic agents, including anticancer drugs.

Purpose of the Study:

• To isolate and characterize a novel natural product from Fomitiporia ellipsoidea.
• To evaluate the antitumor and cytotoxic activities of the isolated compound.

Main Methods:

• Methanolic extraction of Fomitiporia ellipsoidea fruit bodies.
• Structure elucidation using Nuclear Magnetic Resonance (NMR) and Mass Spectrometry (MS).
• In vivo antitumor activity assay against hepatoma H(22) and in vitro cytotoxicity assay against HepG-2 and Skov 3 cell lines.

Main Results:

• A new furan derivative, fomitiporiaester A (1), was successfully isolated and characterized.
• Fomitiporiaester A exhibited significant dose-dependent antitumor activity against hepatoma H(22) in vivo, with inhibition rates up to 58.15%.
• The compound displayed weak cytotoxic activity against human hepatoblastoma (HepG-2) and human oophoroma (Skov 3) cell lines (IC50 > 100 μM).

Conclusions:

• Fomitiporiaester A is a promising natural compound with notable in vivo antitumor efficacy.
• Further research into the mechanism of action and therapeutic potential of fomitiporiaester A is warranted.